PERSPECTA

News from every angle

← Back to headlines

US FDA approves Vanda's antipsychotic pill, shares climb - Reuters

US FDA approves Vanda's antipsychotic pill, shares climb  Reuters

PostShare

Sources

Showing 0 of 2 sources

No articles available in your preferred languages.

2 articles available in other languages below.

seeking-alphasrc49d ago

Vanda surges as FDA approves Bysanti for bipolar disorder, schizophrenia

Read full article →
ReutersSpanish49d ago

US FDA approves Vanda's antipsychotic pill - TradingView

US FDA approves Vanda's antipsychotic pill  TradingView

Read full article →

Coverage Timeline

First report: Reuters · 20 Feb, 23:20Full coverage: 2 · 3hWindow: 3h
Left-leaningCenterRight-leaning
Reuters20 Feb, 23:20First to report

US FDA approves Vanda's antipsychotic pill - TradingView

3h later
seeking-alpha21 Feb, 02:47Latest update

Vanda surges as FDA approves Bysanti for bipolar disorder, schizophrenia

Related Stories

Iloilo Reinstates Health Protocols Amid Extreme Heat

just now

Four arrested for selling P102 million in fake anti-cancer medicines in Makati

23m ago

Danish Healthcare System Needs Clearer Accountability

25m ago

Vigilance Urged After Death of Two Children in Abandoned Car

39m ago